Key Takeaways
- Shares of Figma (FIG) climbed 8.8% Monday, reaching $20.39, despite significant insider selling activity and a dramatic decline following its initial public offering.
- Fourth quarter 2025 revenue jumped 40.1% year-over-year to $303.78M, while EPS of $0.08 significantly exceeded consensus estimates of -$0.20.
- Year-to-date performance shows a devastating 49% loss, with the stock trading substantially beneath its 200-day moving average of $32.08.
- Wall Street analysts maintain a Hold consensus rating, though their average price target of $43.25 represents upside potential exceeding 100%.
- Company insiders dumped approximately 956,362 shares valued at roughly $27.9M during the previous quarter, with CEO Dylan Field selling more than 236,000 shares.
Shares of Figma (FIG) surged 8.8% during Monday’s trading session, finishing at $20.39 after reaching an intraday peak of $20.40. Trading volume registered approximately 4.82 million shares — a significant 67% decline compared to the typical daily average of 14.7 million shares.
The previous session had seen FIG close at $18.74.
Monday’s rally provided temporary relief for shareholders enduring a punishing stretch. Following its July 2025 public debut, the design software company has witnessed a staggering 68% erosion in market value. An additional 49% decline has materialized during 2026 alone.
Technical indicators paint a challenging picture. The 50-day moving average currently registers at $23.11, while the 200-day moving average stands at $32.08. Trading prices remain substantially below both critical thresholds.
Figma’s current market capitalization totals $8.87 billion, accompanied by a price-to-earnings ratio of -6.40 — underscoring the company’s ongoing cash consumption.
Impressive Top-Line Growth Offset by Profitability Challenges
Figma’s most recent quarterly disclosure, published February 18, revealed Q4 2025 revenue of $303.78M — representing robust 40.1% year-over-year expansion. Earnings per share reached $0.08, substantially outperforming Wall Street’s anticipated loss of -$0.20.
However, beneath these encouraging top-line figures lurk concerning profitability metrics. The company operates with a net margin of -121.87% alongside a negative return on equity measuring 97.03%. Full-year earnings projections call for EPS of -$0.69.
Net dollar retention stands at an impressive 136%, indicating existing customers are progressively increasing their platform spending — an encouraging metric amid challenging macroeconomic conditions.
Wall Street Maintains Cautious Stance Despite Elevated Price Targets
Analyst sentiment remains divided. Current coverage breaks down to four Buy ratings, ten Hold recommendations, and one Sell rating. The consensus price target sits at $43.25 — implying approximately 112% upside from Monday’s closing level.
Multiple analysts revised their outlooks downward throughout February. Royal Bank of Canada reduced its target from $38 to $31. Stifel Nicolaus made a similar adjustment, lowering projections from $40 to $30. Morgan Stanley maintains a $44 price objective. Oppenheimer launched coverage in March with a market perform designation.
The substantial disconnect between analyst targets and current trading levels suggests Wall Street believes the selloff has been excessive.
Nevertheless, legitimate competitive concerns persist. Anthropic’s recently launched Claude Design offering has sparked questions regarding potential market share erosion in Figma’s core design collaboration space. Conversely, Figma’s strategic integration with Claude Code could potentially neutralize this competitive dynamic.
CEO Dylan Field executed a sale of 236,930 shares during late February at an average price of $30.77, generating proceeds exceeding $7.29M. General Counsel Brendan Mulligan divested 4,817 shares in March. Collectively, corporate insiders unloaded approximately 956,362 shares worth roughly $27.9M during the recent quarter.
Institutional investor interest continues demonstrating strength. JPMorgan Chase expanded its holdings by 119.4% during Q4. Baillie Gifford increased its position by 93.8%. Prominent early-stage backers including SC US Ttgp, ICONIQ Capital, and a16z each established positions valued above $800M in Q3.
Current analyst projections anticipate full-year EPS of -$0.69 for the ongoing fiscal period.



